semaglutide light headed JEFF ROSE, CFP® | Ozempic has a real warning label, but that doesn't mean every viral headline is giving you the full story. The FDA label for Ozempic GLP-1s | AgelessRx
Description
For patients first prescribed an AOM in December 2024, 50.5% filled a GLP-1 RA within 60 days
Do not discontinue Ozempic without medical guidance, as abrupt cessation may affect your diabetes control
What is the difference between GLP-1 agonists and SGLT2 inhibitors for type 2 diabetes
Ervinna, N., Mita, T., Yasunari, E., Azuma, K., Tanaka, R., Fujimura, S., Sukmawati, D., Nomiyama, T., Kanazawa, A., Kawamori, R., Fujitani, Y., & Watada, H
NICE guidance supports their use in type 2 diabetes for people with established cardiovascular disease or high cardiovascular risk, or when additional therapy is needed despite metformin and/or SGLT2 inhibitors
Its primary benefits are related to weight loss and blood sugar control
